Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
AmyriAD Therapeutics Acquires Recognify Life Sciences, Expanding Its Clinical-Stage Cognition Pipeline with RL-007 (Inidascamine)
07 Oct 2026
PR Newswire Association LLC.
OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry
07 Oct 2026
PR Newswire Association LLC.
Qurin® launches Qatra™ gDNA extraction kit for large-volume urine processing
06 Oct 2026
PR Newswire Association LLC.
Stryker Launches Mako 4 SmartRobotics™ in India, Advancing the Next Generation of Robotic-Assisted Joint Replacement
05 Oct 2026
PR Newswire Association LLC.
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
05 Oct 2026
PR Newswire Association LLC.
Medline launches "10 Minutes That Matter" campaign to spotlight the value of time in the operating theatre
01 Oct 2026
PR Newswire Association LLC.
Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
01 Oct 2026
PR Newswire Association LLC.
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
23 Sep 2026
PR Newswire Association LLC.
Clean Bio Korea to Showcase Indonesia-Validated Air-Fit at Hospital Expo 2026
21 Sep 2026
PR Newswire Association LLC.
Philips OneBlade and Red Bull take self-expression to new heights in Cappadocia, Turkey
15 Sep 2026
PR Newswire Association LLC.
ERS 2026: Objective nighttime cough data linked to subsequent asthma symptom severity, Albus Health reports
14 Sep 2026
PR Newswire Association LLC.
AdJane Unveils Mucosal Booster Strategy for Next-Generation Respiratory Vaccine Franchises
10 Sep 2026
PR Newswire Association LLC.
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
09 Sep 2026
PR Newswire Association LLC.
SkylineDx Expands Direct U.S. Commercial and Clinical Investment to Accelerate Access to Merlin™ CP-GEP
09 Sep 2026
PR Newswire Association LLC.
HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study
08 Sep 2026
GlobeNewswire
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
06 Aug 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
06 Aug 2026
GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
GlobeNewswire
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
05 Aug 2026
GlobeNewswire
Market launch of the nasal adrenaline spray, neffy®, for treatment of adults and children with severe allergies in Canada
05 Aug 2026
GlobeNewswire
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04 Aug 2026
GlobeNewswire
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
04 Aug 2026
GlobeNewswire
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04 Aug 2026
GlobeNewswire
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
03 Aug 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
Upcoming Events All Events
- October 2026
- Yokohama: BioJapan
- Queensland: AusBiotech Invest
- Queensland: AusBiotech International Conference